Lucid Diagnostics (LUCD) Institutional Ownership → He Is Giving Away Bitcoin (From Crypto Swap Profits) (Ad) Free LUCD Stock Alerts $0.95 -0.08 (-7.77%) (As of 05/8/2024 ET) Add Compare Share Share OwnershipStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Institutional Ownership Changes (13F Filings) for Lucid Diagnostics (NASDAQ:LUCD)CurrentInstitutional OwnershipPercentage74.01%Number ofInstitutional Buyers(last 12 months)1TotalInstitutional Inflows(last 12 months)$32.08KNumber ofInstitutional Sellers(last 12 months)0 Get LUCD Insider Trade Alerts Want to know when executives and insiders are buying or selling Lucid Diagnostics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data LUCD Institutional Buying and Selling by Quarter Ad Priority GoldThe 2024 Gold Rush: Unleashing Market PotentialWelcome to the financial rollercoaster of 2024, where inflation is persistent, stock markets are overinflated and volatile, global conflicts are intensifying, and the national debt is reaching new heights.Get your free information kit NOW, before it's too late. Lucid Diagnostics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails8/14/2023Luminus Management LLC878,378$1.22M0.4%+2.7%2.024% 2/13/2023Levin Capital Strategies L.P.36,799$50K0.0%N/A0.094% 11/15/2022Cantor Fitzgerald L. P.264,653$405K0.0%-20.7%0.698% 11/14/2022Luminus Management LLC846,662$1.30M0.5%-3.1%2.232% 11/14/2022Verition Fund Management LLC36,166$55K0.0%-22.6%0.095% 11/10/2022Nantahala Capital Management LLC286,432$438K0.0%-7.3%0.755% 8/15/2022Nantahala Capital Management LLC308,978$698K0.0%-2.0%0.815% 8/15/2022Luminus Management LLC873,804$1.98M0.6%+15.7%2.304% 7/22/2022 Geneos Wealth Management Inc.42,450$98K0.0%-32.0%0.112% 6/2/2022Verition Fund Management LLC36,166$122K0.0%N/A0.095% 5/23/2022Cantor Fitzgerald L. P.333,717$1.12M0.1%-20.0%0.880% 2/15/2022KCL Capital L.P.10,000$54K0.0%N/A0.027% 2/15/2022Covalis Capital LLP134,532$722K0.3%N/A0.365% 2/2/2022 New York State Common Retirement Fund13,800$74K0.0%N/A0.037% 2/1/2022 Kornitzer Capital Management Inc. KS133,000$714K0.0%N/A0.361% (Data available from 1/1/2016 forward) LUCD Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of LUCD shares? During the previous two years, the following institutional investors and hedge funds held shares of Lucid Diagnostics shares: Luminus Management LLC ($1.22M), Nantahala Capital Management LLC ($438K), Cantor Fitzgerald L. P. ($405K), Geneos Wealth Management Inc. ($98K), and Verition Fund Management LLC ($55K), Levin Capital Strategies L.P. ($50K).Learn more on LUCD's institutional investors. What percentage of Lucid Diagnostics stock is owned by institutional investors? 74.01% of Lucid Diagnostics stock is owned by institutional investors. Learn more on LUCD's institutional investor holdings. Which institutional investors have been buying Lucid Diagnostics stock? The following institutional investors have purchased Lucid Diagnostics stock in the last 24 months: Luminus Management LLC ($141.40K), Levin Capital Strategies L.P. ($36.80K), and Verition Fund Management LLC ($36.17K). How much institutional buying is happening at Lucid Diagnostics? Institutional investors have bought a total of 214,365 shares in the last 24 months. This purchase volume represents approximately $471.05K in transactions. Which Lucid Diagnostics major shareholders have been selling company stock? The following institutional investors have sold Lucid Diagnostics stock in the last 24 months: Cantor Fitzgerald L. P. ($152.49K), Nantahala Capital Management LLC ($28.98K), Luminus Management LLC ($27.14K), Geneos Wealth Management Inc. ($20K), and Verition Fund Management LLC ($10.54K). How much institutional selling is happening at Lucid Diagnostics? Institutional investors have sold a total of 239,161 shares in the last 24 months. This volume of shares sold represents approximately $537.89K in transactions. Related Companies: CTSO Major Shareholders DRIO Major Shareholders NSPR Major Shareholders XAIR Major Shareholders CTCX Major Shareholders APYX Major Shareholders CODX Major Shareholders LNSR Major Shareholders MODD Major Shareholders RVP Major Shareholders This page (NASDAQ:LUCD) was last updated on 5/9/2024 by MarketBeat.com Staff From Our PartnersTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsUrgent Nvidia WarningAltimetry348 million Americans lives to END as we know it?The Oxford ClubThe A.I. story nobody is telling you (Read ASAP)TradeSmithTrump’s “Tax Free” Retirement Strategy Gold Safe Exchange Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Lucid Diagnostics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.